Gerhard Hellemann - Concepedia

Author

Gerhard Hellemann

University of California, Los Angeles ORCID

Also Known As

G Hellemann, G S Hellemann, G. Hellemann, G. S. Hellemann, G.S. Hellemann, GERHARD HELLEMANN, Gerhard S. Hellemann, Gerhard Hellemann, Gerhard S Hellemann, Gerhard S. Hellemann

277

Publications

12.1K

Citations

H-Index

188

Concepts

All Affiliations

University of California, Los Angeles Neurobehavioral Systems VA Greater Los Angeles Healthcare System Mental Illness Research, Education and Clinical Centers Brain Mapping Foundation

About

Gerhard Hellemann is an author at University of California, Los Angeles specializing in medicine, psychiatry, and social sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	36	62	4.5K
2	Health Sciences	8	8	466
3	Education	4	4	571
4	Engineering	1	1	27
5	Nursing	1	1	55

Gerhard Hellemann

147

Publications

10.6K

Citations

H-Index

Page 1

	Year	Citations
Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study John M. Ringman, Sally A. Frautschy, Edmond Teng, Alzheimer s Research & Therapy	2012	510
Social Cognition in Schizophrenia, Part 1: Performance Across Phase of Illness Michael F. Green, Carrie E. Bearden, Tyrone D. Cannon, Schizophrenia Bulletin Social PsychologyMental HealthSocial ImpairmentPsychologySocial Sciences	2011	418
Randomized comparative efficacy study of parent-mediated interventions for toddlers with autism. Connie Kasari, Amanda C. Gulsrud, Tanya Paparella, Journal of Consulting and Clinical Psychology	2015	388
From Perception to Functional Outcome in Schizophrenia Michael F. Green, Gerhard Hellemann, William P. Horan, Archives of General Psychiatry	2012	375
Longitudinal Follow-Up of Children With Autism Receiving Targeted Interventions on Joint Attention and Play Connie Kasari, Amanda C. Gulsrud, Stephanny Freeman, Journal of the American Academy of Child & Adolescent Psychiatry Child PsychologyBehavioral SciencesLongitudinal Follow-upEducationAutism	2012	293
Social Cognition in Schizophrenia, Part 2: 12-Month Stability and Prediction of Functional Outcome in First-Episode Patients William P. Horan, Michael F. Green, Michael DeGroot, Schizophrenia Bulletin Neuropsychological FunctioningPsychopathologyPsychiatryRisk PredictionPart 2	2011	279
Effects of Antenatal Depression and Antidepressant Treatment on Gestational Age at Birth and Risk of Preterm Birth Rita Suri, Lori L. Altshuler, Gerhard Hellemann, American Journal of Psychiatry	2007	254
Long-Acting Injectable Risperidone for Relapse Prevention and Control of Breakthrough Symptoms After a Recent First Episode of Schizophrenia Kenneth L. Subotnik, Laurie R. Casaus, Joseph Ventura, JAMA Psychiatry	2015	246
Withdrawal symptoms in abstinent methamphetamine‐dependent subjects Todd Zorick, Liam J. Nestor, Karen Miotto, Addiction	2010	228
A Multisite Randomized Controlled Two-Phase Trial of the Early Start Denver Model Compared to Treatment as Usual Sally J. Rogers, Annette Estes, Catherine Lord, Journal of the American Academy of Child & Adolescent Psychiatry Primary CareClinical TrialsMultisite RandomizedTreatment EffectRandomized Controlled Trial	2019	223

Page 1